OMNIAB INC (OABI) Stock Price, Quote, News and Overview
NASDAQ:OABI - Nasdaq - US68218J1034 - Common Stock - Currency: USD
OABI Quote, Performance and Key Statistics
1.91
-0.04 (-2.05%)
The current stock price of OABI is 1.91 USD. In the past month the price increased by 2.69%. In the past year, price decreased by -56.69%.
OABI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 21.37 | 176.54B | ||
| DHR | DANAHER CORP | 26.18 | 141.10B | ||
| A | AGILENT TECHNOLOGIES INC | 21.26 | 32.61B | ||
| IQV | IQVIA HOLDINGS INC | 16.2 | 32.15B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 30.16 | 25.64B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 34.38 | 17.21B | ||
| WAT | WATERS CORP | 24.25 | 17.19B | ||
| ILMN | ILLUMINA INC | 24.69 | 16.26B | ||
| ICLR | ICON PLC | 12.79 | 13.16B | ||
| MEDP | MEDPACE HOLDINGS INC | 31.76 | 12.28B | ||
| QGEN | QIAGEN N.V. | 21.45 | 10.69B | ||
| RVTY | REVVITY INC | 17.98 | 10.36B |
Related stock screener links
About OABI
Company Profile
OmniAb, Inc. operates as a drug discovery company. The company is headquartered in Emeryville, California and currently employs 114 full-time employees. The company went IPO on 2020-10-09. Its technology platform creates and screens diverse antibody repertoires and is designed to identify optimal antibodies and other target-binding proteins for its partners’ drug development efforts. Central to the OmniAb platform, Biological Intelligence, powers the immune systems of its engineered transgenic animals to create optimized antibody candidates for human therapeutics. Its proprietary transgenic animals, including OmniRat, OmniChicken and OmniMouse are genetically modified to generate antibodies with human sequences to streamline the development of human therapeutic candidates. OmniFlic and OmniClic are fixed or common light-chain rats and chickens, designed to facilitate the discovery of bispecific antibodies. OmniTaur provides cow-inspired antibodies with unique structural characteristics for challenging targets.
Company Info
OMNIAB INC
5980 Horton Street, Suite 600
Emeryville CALIFORNIA US
Employees: 106
Phone: 15102507800
OMNIAB INC / OABI FAQ
What is the stock price of OMNIAB INC today?
The current stock price of OABI is 1.91 USD. The price decreased by -2.05% in the last trading session.
What is the ticker symbol for OMNIAB INC stock?
The exchange symbol of OMNIAB INC is OABI and it is listed on the Nasdaq exchange.
On which exchange is OABI stock listed?
OABI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for OMNIAB INC stock?
14 analysts have analysed OABI and the average price target is 8.03 USD. This implies a price increase of 320.55% is expected in the next year compared to the current price of 1.91. Check the OMNIAB INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is OMNIAB INC worth?
OMNIAB INC (OABI) has a market capitalization of 233.67M USD. This makes OABI a Micro Cap stock.
How many employees does OMNIAB INC have?
OMNIAB INC (OABI) currently has 106 employees.
What are the support and resistance levels for OMNIAB INC (OABI) stock?
OMNIAB INC (OABI) has a resistance level at 2.02. Check the full technical report for a detailed analysis of OABI support and resistance levels.
Is OMNIAB INC (OABI) expected to grow?
The Revenue of OMNIAB INC (OABI) is expected to decline by -10.78% in the next year. Check the estimates tab for more information on the OABI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy OMNIAB INC (OABI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of OABI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of OABI, evaluating the profitability, health, valuation and growth aspects
- OMNIAB INC (OABI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- OMNIAB INC (OABI) Sales and EPS estimates to see what analysts future expectations are.
- OMNIAB INC (OABI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- OMNIAB INC (OABI) Insider and Institutional Ownership to learn about the owners and their transactions.
- OMNIAB INC (OABI) Stock Chart to make your own analysis
- OMNIAB INC (OABI) Latest news and press-releases to stay up to date.
Does OMNIAB INC (OABI) stock pay dividends?
OABI does not pay a dividend.
When does OMNIAB INC (OABI) report earnings?
OMNIAB INC (OABI) will report earnings on 2025-08-06, after the market close.
What is the Price/Earnings (PE) ratio of OMNIAB INC (OABI)?
OMNIAB INC (OABI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.58).
What is the Short Interest ratio of OMNIAB INC (OABI) stock?
The outstanding short interest for OMNIAB INC (OABI) is 8.87% of its float. Check the ownership tab for more information on the OABI short interest.
OABI Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to OABI. When comparing the yearly performance of all stocks, OABI is a bad performer in the overall market: 90.5% of all stocks are doing better.
OABI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to OABI. While OABI has a great health rating, there are worries on its profitability.
OABI Financial Highlights
Over the last trailing twelve months OABI reported a non-GAAP Earnings per Share(EPS) of -0.58. The EPS increased by 9.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -20.01% | ||
| ROE | -22.4% | ||
| Debt/Equity | 0 |
OABI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to OABI. The Buy consensus is the average rating of analysts ratings from 14 analysts.
For the next year, analysts expect an EPS growth of -1.57% and a revenue growth -10.78% for OABI